Alejandro Villageliu (he/him)

Alejandro Villageliu has a diverse work experience spanning different roles and industries. Alejandro is currently working at RxVantage as the EVP (Executive Vice President) of Life Sciences Strategy & Innovation. Prior to this, they held the position of EVP and Head of Enterprise Partnerships (Life Sciences) at RxVantage. Before joining RxVantage, Alejandro worked as an Enterprise Client Partner at the same company.

In 2020, Alejandro also established their own consulting firm called Villageliu Consulting, where they served as the President.

Prior to their consulting venture, Alejandro worked as the Vice President of Healthcare at Quid in 2019. Alejandro also served as the Executive Director of Client Advisory at BioVid Corporation from 2018 to 2019.

Earlier in their career, Alejandro held various leadership positions at companies such as Accenture and IQVIA. At Accenture, they worked as the Principal Director and Commercial Practice Lead for Life Sciences West. At IQVIA, they served as a Principal in the Consulting Services division, specializing in Commercial Strategy.

Alejandro also has experience in the advertising and marketing industry. Alejandro worked at Publicis Health, where they held the roles of Vice President, Group Director of Strategy and Planning at Digitas Health, Senior Director of Strategy and Business Development at Heartbeat, and Group Account Director at Heartbeat.

Prior to their time at Publicis Health, Alejandro worked at McCann Health as the Vice President and Senior Strategist.

Alejandro started their career at ZS Associates as a Consultant and later progressed to the position of Manager.

Alejandro's early experience also includes working at Atkins Engineers as a Consultant/Project Manager.

Alejandro Villageliu earned a BS in Industrial Engineering from the Georgia Institute of Technology, graduating in 1998. Alejandro then pursued higher education and completed an MBA with a focus on Finance, Marketing, and Operations Management at the Wharton School of the University of Pennsylvania from 2002 to 2004.